Can B CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
CANB
Can B CORP8-K: Can B Corp. Completes Holding Company Reorganization, Becomes Subsidiary of Nascent Pharma Holdings
Can B Corp. has completed a holding company reorganization, becoming a wholly-owned subsidiary of Nascent Pharma Holdings, with existing Can B shareholders receiving equivalent shares in Nascent.
CANB
Can B CORPCan B Corp. has decided to discontinue its hemp operations after an equipment auction and will incur costs related to lease termination and stock issuance.
CANB
Can B CORPCan B Corp. has engaged Haynie & Company as its new independent registered public accounting firm, effective May 28, 2024.
CANB
Can B CORPCan B Corp. has dismissed BF Borgers as its independent auditor, effective May 6, 2024, following concerns about the firm's ability to continue as a going concern and an SEC order restricting BF Borgers from practicing before the commission.
CANB
Can B CORPCan B Corp has finalized a $75,000 loan agreement with ClearThink Capital Partners, featuring a convertible note with a significant original issue discount.
CANB
Can B CORPCan B Corp has completed the auction of its hemp division assets for approximately $300,000, and will now focus on commercializing its recently acquired cannabis patents.
CANB
Can B CORPCan B Corp, through its subsidiary Nascent Pharma, has acquired patents for liquid cannabis formulations, including beverages and vape liquids, with potential applications for various medical conditions.
CANB
Can B CORPCan B Corp.'s motion for a temporary restraining order to prevent the sale of its hemp division assets by Arena was denied, leading to a postponed auction.
CANB
Can B CORPCan B Corp. has requested a delay in its injunction motion against Arena, as it explores alternative financing options to resolve the dispute.